Xtandi 40 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DX25F6XNK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 14, 2025, for the supply of Xtandi 40 mg tablets (120-count units) with a ceiling value of $4,169.59. This firm fixed-price delivery order carries an ultimate completion date of July 15, 2025, and represents part of the company's ongoing pharmaceutical supply relationship with the Defense Logistics Agency (DLA) Medical Supply Chain division. The award was made without a set-aside designation, and the place of performance is located in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately $500 million and valid through November 2026. The IDC, operating under the SPE2DB program, enables the DLA to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities worldwide. Xtandi, an oncology treatment medication, falls within the extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables that DMS Pharmaceutical Group provides to military health facilities. The company's position as a critical supplier in the federal pharmaceutical supply chain is reinforced by its consistent contract performance and established vendor registration with the System for Award Management since 2001.
Quick answers
Who was awarded contract SPE2DX25F6XNK?
SPE2DX25F6XNK was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 14, 2025.
How much is contract SPE2DX25F6XNK worth?
The government has obligated $4,170 on SPE2DX25F6XNK.
Is contract SPE2DX25F6XNK an order under another contract?
Yes. SPE2DX25F6XNK is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XNK competed?
The extent of competition for SPE2DX25F6XNK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award